Working... Menu

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03876886
Recruitment Status : Recruiting
First Posted : March 15, 2019
Last Update Posted : March 21, 2019
Information provided by (Responsible Party):
Binghe Xu, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2024
  Estimated Study Completion Date : December 2024